CAS 1282512-48-4: 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
Description:1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl- is a complex organic compound characterized by its multi-ring structure and the presence of various functional groups, including pyrazole and triazole moieties. This compound is typically synthesized for its potential biological activity, particularly in pharmaceutical applications. It may exhibit properties such as anti-inflammatory, antimicrobial, or anticancer effects, although specific biological activities would depend on the precise molecular interactions and mechanisms of action. The presence of multiple heterocycles suggests potential for diverse reactivity and interactions with biological targets. Additionally, the compound's solubility, stability, and reactivity can be influenced by its substituents and overall molecular geometry. As with many synthetic organic compounds, safety and handling precautions are essential, and its use would be governed by regulatory guidelines in research and development contexts.
Formula:C24H28N8O2
InChI:InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)
InChI key:InChIKey=BEUQXVWXFDOSAQ-UHFFFAOYSA-N
SMILES:O=C(N)C(N1N=CC(=C1)C2=CC=C3C(OCCN4C=C(N=C34)C5=NC(=NN5C(C)C)C)=C2)(C)C
- Synonyms:
- 1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-
- GDC 0032
- Taselisib
- RG 7604
- 4-[5,6-Dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-α,α-dimethyl-1H-pyrazole-1-acetamide